VCYT Stock Analysis: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$38.08
-0.66 (-1.70%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 23, 2026
23d
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VCYT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: VCYT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.63
Based on -1.9% avg growth
INTRINSIC VALUE TODAY
$21.50
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $38.08, which is considered oversold relative to its 30-day fair value range of $40.40 to $43.97. The stock's valuation (Forward PE: 25.3) is in line with its historical norms (26.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This pessimistic expectation contrasts with the company's recent 26.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VCYT is showing support break momentum. The price is currently testing key support at $37.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VCYT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $47.67 (+23.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VCYT is showing support break momentum. The price is currently testing key support at $37.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VCYT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $47.67 (+23.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$40.40 -
$43.97
Company Quality Score
40/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding VCYT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.0% below Wall St target ($47.67)
- CAUTION: 5-day price weakness (-10.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$40.40 -
$43.97
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$3.29
(8.6%)
Support & Resistance Levels
Support Level
$37.47
Resistance Level
$45.55
Current Trend
Support Break
Fundamental Context
Forward P/E (Next Year Est.)
25.30
Wall Street Target
$47.67
(+23.0%)
Revenue Growth (YoY)
13.8%
Earnings Growth (YoY)
26.3%
Profit Margin
6.1%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
25.3 vs 26.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$38.04
(-2%)
2-Year Target
$37.36
(-4%)
3-Year Target
$36.69
(-5%)
3-Yr Target (if PE normalizes)
(PE: 25→27)
$38.72
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.3, Growth: -7.8%)
$30.41
(+-22%)
Base:
(SPY PE: 22.3, Growth: -7.8%)
$26.81
(-31%)
Bear:
(PE: 19.0, Growth: -7.8%)
$22.79
(-41%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Forward PE: 27.78 | Forward EPS (Implied): $1.39
Bull Case
$46.78
(+21%)
Analyst growth 15.0%, PE expands to 29.2
Base Case
$38.74
(0%)
Market implied 0.0%, PE stable at 27.8
Bear Case
$29.64
(-24%)
Severe decline -15.0%, PE contracts to 25.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.3 to 26.7
Stabilization Target:
$40.89
(+5.6%)
PE Expansion Potential:
+5.6%
Last updated: January 30, 2026 5:36 PM ET
Data refreshes hourly during market hours. Next update: 6:36 PM
Data refreshes hourly during market hours. Next update: 6:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Phillip G Febbo
SELL
8349 shares
2025-10-06
Annie Mcguire
SELL
2283 shares
2025-09-19
Marc Stapley
SELL
7667 shares
2025-09-04
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced VCYT Option Strategies
Professional options setups generated by AI based on today's VCYT price and gamma walls.
